4
Changes in Ownership
Pacira BioSciences, Inc. Filed Acc 0001628280-25-052038
Chief Financial Officer sold 12,060 shares at $22.09 ($266,405)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cross Shawn Chief Financial Officer | 2025-11-10 | Sale 10b5-1 | −12,060 | $22.09 | $266,405 | 56,250 | D |
| Open-market sales · 12,060 sh · avg $22.09 · $266,405 | |||||||
Loading xslF345X05/wk-form4_1763068400.xml…